Website & contact details
- Website
Panthera Biopartners Limited
- Incorporated
- 4 December 2018 (7 years)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Christopher James DoddStuart Young
- Owned by
- Accounts type
- Medium
- Region
- North West
- Address
- 228 Garstang RoadFulwoodPrestonPR2 9QB
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 17 December 2026
- Last conf. stmt
- 3 December 2025
Charges
- Total
- 5
- Outstanding
- 3
- Part satisfied
- 0
- Satisfied
- 2
Officers 3 active
Officer details are public data from the Companies House register.
Director · Appointed 2 January 2024
British
Born November 1977
Dodd, Christopher James
Director · Appointed 26 July 2023
British
Born January 1981 (45)
Young, Stuart
Director · Appointed 22 September 2020
British
Born March 1983 (43)
Officer history (10 former)
8 August 2025
8 August 2025
8 August 2025
Resigned Lock, Jane Marie as Director
8 August 2025
21 July 2024
Appointed Lock, Jane Marie as Director
5 January 2024
2 January 2024
21 August 2023
Resigned Steed, Christopher John as Director
26 July 2023
26 July 2023
26 July 2023
Appointed Dodd, Christopher James as Director
21 April 2023
31 March 2023
Resigned Lyon, Stephen John as Director
9 September 2022
Resigned Smalley, Paul William as Secretary
14 April 2022
14 April 2022
11 November 2021
Resigned Lyon, Stephen John as Secretary
1 June 2021
Appointed Smalley, Paul William as Secretary
14 January 2021
Appointed Steed, Christopher John as Director
22 September 2020
Appointed Young, Stuart as Director
4 December 2018
Appointed Lyon, Stephen John as Secretary
4 December 2018
Appointed Lyon, Stephen John as Director
4 December 2018
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 8 August 2025
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 16607237
Former controllers (2)
24 November 2020
24 November 2020
Ceased Stephen John Lyon — Owns 25–50% of shares
Financials
Figures from 2021 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £1,497,861
- up £323,121 (28%)
- Cash
- £132,214
- down £1,075,291 (89%)
- Employees
- 72
- up 42 (140%)
- Debt Ratio
- 33%
- Current Ratio
- 3.9x
Balance sheet detail
| 2021 | |
|---|---|
| Fixed Assets | £341,259 |
| Current Assets | £1,891,094 |
| Debtors | £1,758,880 |
| Cash | £132,214 |
| Creditors (< 1 year) | £480,714 |
| Net Current Assets | £1,410,380 |
| Net Assets | £1,497,861 |
| Shareholder Funds | £1,497,861 |
What Panthera Biopartners say about themselves
“Take part in paid clinical trials with Panthera Clinic. We run safe, professional medical research studies across the UK for a range of health conditions.”
Filings 98
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 14 September 2026 | Share capital filing | |||
| 14 September 2026 | Insolvency filing | |||
| 14 September 2026 | Statement of capital | |||
| 14 September 2026 | Resolutions | |||
| 18 June 2026 | Accounts for a medium company | 31 December 2025 |
Some other companies at this address
Other companies in this industry
Melbourn
London
Edinburgh
West Mains Road
Penicuik
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →